Fzata, Inc., a biotech innovator, is proud to announce that it has been named the winner of the 2022 Mid-Atlantic Innovation Celebration for Biotechnology for its oral Bioengineered Probiotic Yeast Medicines (BioPYM™) platform. The Company is honored to have been selected for this award from among so many highly innovative competitors.

Fzata is a near-clinical stage platform biopharmaceutical company. Our vision is to reduce health inequities by expanding patient access to therapeutic biologics with patient friendly oral capsules. BioPYM uses  live yeast as a ‘micro-factory’ to make biologics in the gut for GI diseases.